Recombinomics | Elegant Evolution






Home Founder What's New In The News Consulting





























H1N1 Consulting

Paradigm Shift

Viral Evolution

Intervention Monitoring

Vaccine Screening

Vaccine Development

Expression Profiling

Drug Discovery

Custom Therapies

Patents 



Audio:Apr15 Apr18 Apr29 MAP RSS Feed twitter News Now                         

Commentary

H7N9 Zaozhuang Shandong Cluster Raises Concerns
Recombinomics Commentary 03:15
April 29, 2013

Patients Zhang, male, 36 years old, who lives in Zaozhuang City, and engaged in the work of building materials wholesale. Fever, cough 6 days, hold breath after 1 day the Zaozhuang City hospital on the evening of April 21, admitted to hospital with severe pneumonia
 
In Shandong, experts confirmed an H7N9 bird flu case in the city of Zaozhuang on Sunday. The patient, a four-year-old boy surnamed Zhang, developed a fever on Saturday.
 
The above translation (in red) describes the first confirmed H7N9 case (36M) in Zaozhuang, Shandong Province, who developed symptoms on April 15 (see map).  The comments (in blue) describe the confirmation of H7N9 in his son (4M), who developed symptoms on April 27.  The 12 day gap in disease onset dates strongly signals human to human transmission.  Similar time gaps exist for family members in other H7N9 bird flu clusters, including the Minghan familial cluster where disease onset dates between son and father was 8 days (both cases died).
 
Although the disease onset date gaps provided compelling evidence of human to human (H2H) transmission, the evidence for sustained H2H transmission is the identity in three genes found on A/Hangzhou/1/2013 and A/Jiangsu/01/2013, which included L226I

The dramatic spread of confirmed cases in recent days (see map) also supports widespread H2H transmission.

Media Link

Recombinomics Presentations

Recombinomics Publications

Recombinomics Paper at Nature Precedings















Home | Founder | What's New | In The News | Contact Us

Webmaster: webmaster@recombinomics.com
© 2013 Recombinomics.  All rights reserved.